Pekin, 8 Kanama 2025- Beijing Kwinbon Technology Co., Ltd. (Kwinbon) yatangaje uyu munsi ko agace kayo k’ibizamini byihuse ku bisigazwa bya beta-agonist ("ifu y’inyama zinanutse") byageze ku musaruro ushimishije mu isuzuma riherutse gukorwa n’ikigo cy’igihugu gishinzwe kugenzura ubuziranenge bw’ibiribwa mu Bushinwa (Beijing) (NFQIC).
Muri NFQIC yo mu 2025 isuzuma beta-agonist yihuta y’ibicuruzwa birinda immunoassay muri Mata, ibicuruzwa bitanu byipimishije byatanzwe na Kwinbon byagaragaje imikorere itagira inenge. Ibicuruzwa byasuzumwe birimo ibizamini byabugenewe kugirango hamenyekane ibisigisigi byaSalbutamol, Ractopamine, na Clenbuterol, hamwe na Triple Test Strip hamwe na rusangeBeta-AgonistIkizamini cyibiyobyabwenge.
Icy'ingenzi, ibicuruzwa byose byagezweho a0% igipimo cyiza cyibinyoma na 0% igipimo kibi. Byongeye kandiigipimo nyacyo cyo gutahura ibipimo byose byari 100%. Ibisubizo bidasanzwe bishimangira ibyiyumvo bihanitse, umwihariko, n’ubwizerwe bwa tekinoroji ya Kwinbon yihuse yo kumenya ibisigazwa bya beta-agonist bibujijwe mu biryo no mu mibare bifitanye isano.
Icyicaro gikuru kiri i Beijing muri Zhongguancun mu rwego rwo kwerekana udushya two kwerekana udushya tw’igihugu, Kwinbon ni ikigo cy’igihugu cy’ikoranabuhanga cyemewe cy’inzobere mu bijyanye na R&D, inganda, no guteza imbere ibizamini byihuta n’ibikoresho by’ibintu byangiza mu biribwa, ibidukikije, na farumasi. Isosiyete kandi itanga inama zo kugerageza na serivisi tekinike.
Kwinbon kwiyemeza ubuziranenge bishimangirwa nimpamyabumenyi zirimo ISO 9001 (Gucunga ubuziranenge), ISO 13485 (Ibikoresho byubuvuzi QMS), ISO 14001 (Gucunga ibidukikije), na ISO 45001 (Ubuzima n’umutekano ku kazi). Ifite ibyamamare byigihugu mu rwego rwa "Uruganda ruto" (Uruganda rwihariye, rutunganijwe, rutandukanye, kandi rushya), uruganda rukomeye mu nganda zihutirwa z’igihugu, hamwe n’umushinga ufite inyungu z’ubwenge.
Iri suzuma ryakozwe na NFQIC ryemewe ryashimangiye umwanya wa Kwinbon nkumuyobozi wambere utanga ibisubizo nyabyo kandi byizewe byihuse byo gupima umutekano wibiryo no gukumira ikoreshwa rya beta-agoniste mu buryo butemewe n’ubworozi. Amanota meza cyane mubikorwa byose byingenzi byerekana ibipimo ngenderwaho byerekana tekinoroji yihuse yo gutahura.
Igihe cyo kohereza: Kanama-08-2025